-128.5 (s, (E)-CF CF); GC-EIMS (70 eV) m/z (% relative
intensity) (Z)-6: 308 (M+, 40), 185 (68), 157 (43), 135 (63), 126
(25), 123 (24), 107 (58), 92 (63), 77 (100), 64 (42), 63 (23); (E)-6:
308 (M+, 35), 185 (66), 157 (41), 154 (20), 135 (61), 126 (24), 123
(23), 107 (58), 92 (66), 77 (100), 64 (44), 63 (25).
1,2-Bis(4-bromophenoxy)-1,1,2-trifluoroethane (10)
1-Bromo-4-(trifluorovinyloxy)benzene (1) (400 mg, 1.58 mmol),
p-bromophenol (274 mg, 1.58 mmol), and Cs2CO3 (258 mg,
0.79 mmol) in DMF (4 mL) and DI H2O (10 L) were placed
◦
in a preheated oil bath at 60 C and allowed to stir for 1 h. The
mixture was then treated with DI H2O (25 mL). The organic layer
was separated and the aqueous layer was extracted with Et2O
(2 25 mL). The combined organic layers were washed with water
(2 50 mL), dried over MgSO4, filtered over a pad of silica gel, and
concentrated under vacuum affording 10 as an oily yellow solid
(493 mg, 73%). 1H NMR (300 MHz, CDCl3) d 7.52–7.48 (m), 7.13
(d, J = 8.9 Hz), 7.04 (d, J = 8.6 Hz), 5.84 (dt, J = 58.4 Hz, 3.1 Hz,
CHFCF2); 19F NMR (283 MHz, CDCl3) d -85.4 and -85.9 (AB
pattern, Jab = 148.1 Hz, CHFCF2), -138.9 (dt, J = 59.26 Hz, 8.2
Hz, CHFCF2); GC-EIMS (70 eV) m/z (% relative intensity) 428,
426, 424 (M+, 49, 100, 51), 205, 203 (54, 56), 157, 155 (92, 99), 145,
143 (35, 34), 76 (48), 75 (41), 64 (39), 63 (55), 50 (43).
(Z)- and (E)-1-(2-Bromophenoxy)-2-(4-bromophenoxy)-1,2-
difluoroethene ((Z)/E)-7)
o-Bromophenol (274 mg, 1.58 mmol), sodium hydride (152 mg,
6.32 mmol) and 1-bromo-4-(trifluorovinyloxy)benzene (1)
(400 mg, 1.58 mmol) were used following the procedure outlined
for the preparation of (Z)/(E)-3 affording the product mixture
1
(Z)/(E)-7 as a yellow oil (441 mg, 69%). H NMR (300 MHz,
CDCl3) d 7.52–7.00 (m); 19F NMR (283 MHz, CDCl3) d -120.9
and -121.2 (d, J = 42.8 Hz, (Z)-CF CF), -126.9 and -127.8 (d,
J = 111.9 Hz, (E)-CF CF); GC-EIMS (70 eV) m/z (% relative
intensity) (Z)-7: 408, 406, 404 (M+, 12, 22, 12), 235, 233 (19, 18),
207, 205 (17, 18), 185, 183 (19, 19), 157, 155 (97, 100), 152 (14),
76 (83), 75 (91), 74 (21), 63 (13), 51 (15), 50 (96); (E)-7: 408, 406,
404 (M+, 12, 23, 11), 235 (17, 18), 207, 205 (16, 16), 185, 183 (18,
19), 157, 155 (94, 100), 126 (12), 76 (86), 75 (85), 74 (20), 63 (12),
51 (14), 50 (95).
(Z)- and (E)-1-(4-Bromophenoxy)-2-(ethyloxy)-1,2-difluoroethene
((Z)/(E)-11)
Anhydrous sodium ethoxide (57 mg, 0.830 mmol) and 1-bromo-
4-(trifluorovinyloxy)benzene (1) (200 mg, 0.790 mmol) were used
following the procedure outlined for the preparation of (Z)/(E)-3
affording the product mixture (Z)/(E)-11 as a yellow oil (190 mg,
86%). 1H NMR (300 MHz, CDCl3) d 7.42 (d, J = 8.9 Hz), 6.96 (d,
J = 8.9 Hz), 4.10 and 3.99 (q, J = 6.8 Hz, -CH2CH3), 1.25 and 1.28
(q, J = 6.8 Hz, -CH2CH3); 19F NMR (283 MHz, CDCl3) d -120.9
and -126.9 (d, J = 39.5 Hz, (Z)-CF CF), -127.3 and -133.6 (d,
J = 108.6 Hz, (E)-CF CF); GC-EIMS (70 eV) m/z (% relative
intensity) (Z)-11: 280, 278 (M+, 19, 18), 252, 250 (28, 26), 158 (40),
156 (42), 157, 155 (96, 94), 77 (100), 76 (65), 75 (62), 74 (18), 50
(63); (E)-11: 280, 278 (M+, 17, 17), 252, 250 (29, 29), 158 (40), 156
(43), 157, 155 (93, 100), 77 (98), 76 (63), 75 (64), 74 (17), 50 (62).
(Z)- and (E)-1-(4-Bromophenoxy)-2-(2-tert-butylphenoxy)-1,2-
difluoroethene ((Z)/(E)-8)
o-tert-Butylphenol (238 mg, 1.58 mmol), sodium hydride
(152 mg, 6.32 mmol) and 1-bromo-4-(trifluorovinyloxy)benzene
(1) (400 mg, 1.58 mmol) were used following the procedure
outlined for the preparation of (Z)/(E)-3 affording the product
mixture (Z)/(E)-8 as a yellow oil (304 mg, 50%). 1H NMR
(300 MHz, CDCl3) d 7.51–6.97 (m), 1.45 (s, -C(CH3)3), 1.35 (s,
-C(CH3)3); 19F NMR (283 MHz, CDCl3) d -120.7 and -122.3 (d,
J = 42.8 Hz, (Z)-CF CF), -126.8 and -129.2 (d, J = 108.6 Hz,
(E)-CF CF); GC-EIMS (70 eV) m/z (% relative intensity) (Z)-8:
384, 382 (M+, 6, 6), 157, 155 (4, 4), 117, 115 (4, 4), 105 (12), 92 (8),
91 (100), 77 (6), 76 (5), 75 (5), 65 (3), 55 (22), 51 (3), 50 (5); (E)-8:
384, 382 (M+, 6, 7), 157, 155 (4, 4), 117, 115 (4, 4), 105 (11), 92 (8),
91 (100), 77 (5), 76 (5), 75 (5), 55 (22), 51 (3), 50 (6).
General procedure for the isolation of (Z)- and (E)-isomers
Dispersion of the vacuum dried (Z)- and (E)-isomer mixture in
MeOH (10–20 mL) precipitated exclusively the (E)-isomer as a
white or yellow solid, which was filtered and dried in vacuum.
This process was typically repeated 5–10 times to separate the (E)-
isomer affording >90% pure isolated (Z)-isomer as a yellow oil.
X-ray quality white crystals were produced by recrystallization of
the combined precipitates of the (E)-isomers of 3 and 6 from slow
evaporation in diethyl ether at room temperature.
(Z)- and (E)-1-(4-Bromophenoxy)-2-(2-phenylphenoxy)-1,2-
difluoroethene ((Z)/(E)-9)
o-Phenylphenol (269 mg, 1.58 mmol), sodium hydride (152 mg,
6.32 mmol) and 1-bromo-4-(trifluorovinyloxy)benzene (1)
(400 mg, 1.58 mmol) were used following the procedure outlined
for the preparation of (Z)/(E)-3 affording the product mixture
Dehydrofluorination of 10
1
(Z)/(E)-9 as a yellow oil (429 mg, 67%). H NMR (300 MHz,
1,2-Bis(4-bromophenoxy)-1,1,2-trifluoroethane (10) (100 mg,
CDCl3) d 7.80–7.20 (m), 7.15–6.74 (m); 19F NMR (283 MHz,
CDCl3) d -120.2 and -122.3 (d, J = 42.8 Hz, (Z)-CF CF), -127.3
and -128.8 (d, J = 111.9 Hz, (E)-CF CF); GC-EIMS (70 eV) m/z
(% relative intensity) (Z)-9: 404, 402 (M+, 8, 9), 231 (13), 230 (26),
200 (42), 199 (54), 183 (10), 181 (17), 157, 155 (9, 9), 153 (51), 152
(100), 151 (26), 127 (8), 77 (7), 76 (15), 75 (15), 51 (8), 50 (13);
(E)-9: 404, 402 (M+, 9, 8), 231 (12), 230 (25), 200 (40), 199 (56),
183 (9), 181 (17), 157, 155 (8, 9), 153 (50), 152 (100), 151 (24), 127
(7), 76 (16), 75 (16), 51 (8), 50 (15).
1.58 mmol), sodium hydride (14 mg, 0.587 mmol) in DMF (3 mL)
were placed in a preheated oil bath at 60 C and allowed to stir
◦
for 24 h. The mixture was then treated with DI H2O (10 mL). The
organic layer was separated and the aqueous layer was extracted
with Et2O (2 10 mL). The combined organic layers were washed
with water (2 10 mL), dried over MgSO4, filtered over a pad of
silica gel, and concentrated under vacuum. 19F NMR (283 MHz,
CDCl3) peak integration showed 71% conversion to (Z)/(E)-3 in
a 1.16 : 1 isomer ratio with the remaining as unreacted 10.
4848 | Org. Biomol. Chem., 2011, 9, 4842–4849
This journal is
The Royal Society of Chemistry 2011
©